Snowflakes Biology: It is expected to have a net profit attributable to the parent company of 29-40 million yuan in 2025, compared to a loss of 617 million yuan in the same period last year.

Xuerong Biology announced on January 15 that it is expected to achieve a net profit attributable to shareholders of 29 million to 40 million yuan in 2025, compared to a loss of 617 million yuan in the same period last year. The company stated that in 2025, it will adhere to prudent operation, solidify various business areas, consolidate its foundation, and achieve a breakthrough in the independently cultivated new strain of white golden needle mushroom. With the advantage of seed sources, the company will reverse its losses, and overall operating performance will significantly improve year-on-year.